Vital Edge review

This is an unusually complete shelf. Compounded semaglutide and tirzepatide, branded Ozempic, Mounjaro, Wegovy and Rybelsus, three-month bundles, and compounded oral capsules of both molecules — all with figures on them before any intake. The orals matter most for anyone who will not inject: a needle-free route with a real published price is rare, and here there are two. Every card also states the fee is flat with no upcharge based on dose, which is the structure that keeps a small dose from funding somebody else's ladder. Two things need reading slowly. Each compounded card defines the monthly fee as four weekly injections, and four weeks is not a month — billed that way a year holds thirteen cycles, so the real annual figure runs about eight percent above the number on the card. And each compounded card prints a clinical-trial weight-loss range next to itself. Those percentages come from trials of the branded drugs. A compounded preparation is not what was tested, and attaching the figure to one lends it evidence it has not earned. The consult fee charged when nothing is prescribed is at least disclosed on the page rather than discovered later.

Vs median

$181/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Vital Edge dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Vital Edge publishes more of its catalog than almost anyone here: compounded semaglutide and tirzepatide, branded Ozempic, Mounjaro, Wegovy and Rybelsus, three-month bundles, and — unusually — compounded ORAL capsules of both molecules, which is a needle-free route with a real price on it rather than a waiting list. Every card says the monthly fee is flat with no upcharge based on dose, which is the structure a low-dose buyer wants. Two things need reading closely. The compounded cards define the month as four weekly injections, and four weeks is not a month: billed that way the year holds thirteen cycles, so the true annual cost runs about 8% above the figure on the card. And each compounded card attaches a clinical-trial weight-loss range to itself. Those percentages come from trials of the branded drugs; a compounded preparation was not what was tested, and borrowing the number lends it evidence it does not have. The $80 consult fee if nothing is prescribed is disclosed rather than hidden, which is more than most manage.

A "month" on the compounded plans is four weekly injections, so a year costs about 8% more than the monthly figure implies.

• Clinical-trial weight-loss percentages are printed on compounded products; those trials tested the branded drugs.
• No compounding pharmacy is named.

Vital Edge is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Oral semaglutide (Rybelsus)
• The true annual cost of a plan
• What a flat price costs at a low dose